{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["IBS", "Myrrh", "RBL-2H3", "chamomile flower", "chronic disease", "mast cells", "natural compounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36559534", "DateRevised": {"Year": "2022", "Month": "12", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "08"}], "Language": ["eng"], "ELocationID": ["3422", "10.3390/plants11243422"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "24", "PubDate": {"Year": "2022", "Month": "Dec", "Day": "08"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Myrrh and Chamomile Flower Extract Inhibit Mediator Release from IgE-stimulated Mast-Cell-Like RBL-2H3 Cells.", "Abstract": {"AbstractText": ["Recent clinical evidence supports the efficacy of a traditional medicinal product (TMP) containing a combination of myrrh (<i>Commiphora myrrha</i> (Nees) Engl.), coffee charcoal (<i>Coffea arabica</i> L.), and chamomile flower dry extract (<i>Matricaria chamomilla</i> L.) in the therapy of diarrhea and inflammatory bowel disease. Mast cells seem to play a key role in the symptom generation of irritable bowel syndrome (IBS). To evaluate the use of the TMP in IBS treatment, the effects of the herbal extracts on the release of mast-cell mediators from stimulated RBL-2H3 cells were investigated. Therefore, degranulation was induced by phorbol-12-myristate-13-acetate (PMA) and calcium ionophore A13187 (CI) or IgE stimulation, and the amounts of released \u03b2-hexosaminidase and histamine were quantified. The extracts showed no effect on the mediator release of PMA- and CI-stimulated RBL-2H3 cells. Myrrh and chamomile were able to reduce the \u03b2-hexosaminidase release of IgE-stimulated cells, while myrrh showed stronger inhibition of the mediator release than chamomile, which reduced only IgE-stimulated histamine release. Thus, these results indicate a mechanistic basis for the use of the herbal combination of myrrh, coffee charcoal, and chamomile flower extract in the symptom-oriented treatment of IBS patients with diarrheal symptoms."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medical Physics and Biophysics, Medical Faculty, Leipzig University, H\u00e4rtelstr. 16-18, 04107 Leipzig, Germany."}, {"Identifier": [], "Affiliation": "Repha GmbH Biologische Arzneimittel, Alt-Godshorn 87, 30855 Langenhagen, Germany."}], "LastName": "Altenbernd", "ForeName": "Fabian", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medical Physics and Biophysics, Medical Faculty, Leipzig University, H\u00e4rtelstr. 16-18, 04107 Leipzig, Germany."}], "LastName": "Schwarz", "ForeName": "Lena", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Repha GmbH Biologische Arzneimittel, Alt-Godshorn 87, 30855 Langenhagen, Germany."}], "LastName": "Lipowicz", "ForeName": "Bartosz", "Initials": "B"}, {"Identifier": ["0000-0002-4563-1493"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medical Physics and Biophysics, Medical Faculty, Leipzig University, H\u00e4rtelstr. 16-18, 04107 Leipzig, Germany."}, {"Identifier": [], "Affiliation": "Repha GmbH Biologische Arzneimittel, Alt-Godshorn 87, 30855 Langenhagen, Germany."}], "LastName": "Vissiennon", "ForeName": "Cica", "Initials": "C"}], "GrantList": [{"GrantID": "BGAAF-0750", "Agency": "Repha (Germany)", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "Authors: Fabian Altenbernd, Bartosz Lipowicz and Cica Vissiennon are employed by Repha GmbH Biologische Arzneimittel. Lena Schwarz has no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014;6:71\u201380.", "ArticleIdList": ["PMC3921083", "24523597"]}, {"Citation": "Simr\u00e9n M., Brazier J., Coremans G., Dapoigny M., M\u00fcller-Lissner S.A., Pace F., Smout A.J.P.M., Stockbr\u00fcgger R.W., Vatn M.H., Whorwell P.J. Quality of life and illness costs in irritable bowel syndrome. Digestion. 2004;69:254\u2013261. doi: 10.1159/000079846.", "ArticleIdList": ["10.1159/000079846", "15256832"]}, {"Citation": "Wouters M.M., Vicario M., Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155\u2013168. doi: 10.1136/gutjnl-2015-309151.", "ArticleIdList": ["10.1136/gutjnl-2015-309151", "26194403"]}, {"Citation": "Matricon J., Meleine M., Gelot A., Piche T., Dapoigny M., Muller E., Ardid D. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2012;36:1009\u20131031. doi: 10.1111/apt.12080.", "ArticleIdList": ["10.1111/apt.12080", "23066886"]}, {"Citation": "Santos J., Saperas E., Nogueiras C., Mourelle M., Antol\u00edn M., Cadahia A., Malagelada J.-R. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology. 1998;114:640\u2013648. doi: 10.1016/S0016-5085(98)70577-3.", "ArticleIdList": ["10.1016/S0016-5085(98)70577-3", "9516384"]}, {"Citation": "Hardcastle J., Hardcastle P.T. The secretory actions of histamine in rat small intestine. J. Physiol. 1987;388:521\u2013532. doi: 10.1113/jphysiol.1987.sp016629.", "ArticleIdList": ["10.1113/jphysiol.1987.sp016629", "PMC1192563", "2888885"]}, {"Citation": "Russell D.A. Mast cells in the regulation of intestinal electrolyte transport. Am. J. Physiol. 1986;251:G253\u2013G262. doi: 10.1152/ajpgi.1986.251.2.G253.", "ArticleIdList": ["10.1152/ajpgi.1986.251.2.G253", "2426973"]}, {"Citation": "Mall M., Gonska T., Thomas J., Hirtz S., Schreiber R., Kunzelmann K. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am. J. Physiol. Gastrointest. Liver Physiol. 2002;282:G200\u2013G210. doi: 10.1152/ajpgi.00137.2001.", "ArticleIdList": ["10.1152/ajpgi.00137.2001", "11804840"]}, {"Citation": "Mart\u00ednez C., Lobo B., Pigrau M., Ramos L., Gonz\u00e1lez-Castro A.M., Alonso C., Guilarte M., Guil\u00e1 M., de Torres I., Azpiroz F., et al. Diarrhoea-predominant irritable bowel syndrome: An organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013;62:1160\u20131168. doi: 10.1136/gutjnl-2012-302093.", "ArticleIdList": ["10.1136/gutjnl-2012-302093", "22637702"]}, {"Citation": "Bueno L. Protease activated receptor 2: A new target for IBS treatment. Eur. Rev. Med. Pharmacol. Sci. 2008;12((Suppl. 1)):95\u2013102.", "ArticleIdList": ["18924448"]}, {"Citation": "Barbara G., Wang B., Stanghellini V., de Giorgio R., Cremon C., Di Nardo G., Trevisani M., Campi B., Geppetti P., Tonini M., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26\u201337. doi: 10.1053/j.gastro.2006.11.039.", "ArticleIdList": ["10.1053/j.gastro.2006.11.039", "17241857"]}, {"Citation": "Buhner S., Li Q., Vignali S., Barbara G., de Giorgio R., Stanghellini V., Cremon C., Zeller F., Langer R., Daniel H., et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009;137:1425\u20131434. doi: 10.1053/j.gastro.2009.07.005.", "ArticleIdList": ["10.1053/j.gastro.2009.07.005", "19596012"]}, {"Citation": "Feng B., La J.H., Schwartz E.S., Gebhart G.F. Irritable bowel syndrome: Methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;302:G1085\u2013G1098. doi: 10.1152/ajpgi.00542.2011.", "ArticleIdList": ["10.1152/ajpgi.00542.2011", "PMC3362095", "22403791"]}, {"Citation": "Klooker T.K., Braak B., Koopman K.E., Welting O., Wouters M.M., van der Heide S., Schemann M., Bischoff S.C., van den Wijngaard R.M., Boeckxstaens G.E. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213\u20131221. doi: 10.1136/gut.2010.213108.", "ArticleIdList": ["10.1136/gut.2010.213108", "20650926"]}, {"Citation": "Wang J., Wang Y., Zhou H., Gu W., Wang X., Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur. J. Gastroenterol. Hepatol. 2020;32:706\u2013712. doi: 10.1097/MEG.0000000000001737.", "ArticleIdList": ["10.1097/MEG.0000000000001737", "32317585"]}, {"Citation": "Nellesen D., Yee K., Chawla A., Lewis B.E., Carson R.T. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J. Manag. Care Pharm. JMCP. 2013;19:755\u2013764. doi: 10.18553/jmcp.2013.19.9.755.", "ArticleIdList": ["10.18553/jmcp.2013.19.9.755", "24156644"]}, {"Citation": "Layer P., Andresen V., Pehl C.H.A., Bischoff S.C., Cla\u00dfen M., Enck P., Frieling T., Haag S., Holtmann G., Karaus M., et al. S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft f\u00fcr Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Neurogastroenterologie und Motilit\u00e4t (DGNM) [Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management] Z Gastroenterol. 2011;49:237\u2013293.", "ArticleIdList": ["21287438"]}, {"Citation": "Albrecht U., M\u00fcller V., Schneider B., Stange R. Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: A non-interventional study. BMJ Open Gastroenterol. 2014;1:e000015. doi: 10.1136/bmjgast-2014-000015.", "ArticleIdList": ["10.1136/bmjgast-2014-000015", "PMC4533328", "26462267"]}, {"Citation": "Vissiennon C., Goos K.-H., Goos O., Nieber K. Antispasmodic effects of myrrh due to calcium antagonistic effects in inflamed rat small intestinal preparations. Planta Med. 2015;81:116\u2013122. doi: 10.1055/s-0034-1383391.", "ArticleIdList": ["10.1055/s-0034-1383391", "25590370"]}, {"Citation": "Vissiennon C., Hammoud D., Rodewald S., Fester K., Goos K.H., Nieber K., Arnhold J. Chamomile Flower, Myrrh, and Coffee Charcoal, Components of a Traditional Herbal Medicinal Product, Diminish Proinflammatory Activation in Human Macrophages. Planta Med. 2017;83:846\u2013854. doi: 10.1055/s-0043-104391.", "ArticleIdList": ["10.1055/s-0043-104391", "28264206"]}, {"Citation": "Weber L., Kuck K., J\u00fcrgenliemk G., Heilmann J., Lipowicz B., Vissiennon C. Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa. Biomolecules. 2020;10:1033. doi: 10.3390/biom10071033.", "ArticleIdList": ["10.3390/biom10071033", "PMC7407830", "32664498"]}, {"Citation": "Weber L., Hammoud Mahdi D., Jankuhn S., Lipowicz B., Vissiennon C. Bioactive Plant Compounds in Coffee Charcoal (Coffeae carbo) Extract Inhibit Cytokine Release from Activated Human THP-1 Macrophages. Molecules. 2019;24:4263. doi: 10.3390/molecules24234263.", "ArticleIdList": ["10.3390/molecules24234263", "PMC6930648", "31766780"]}, {"Citation": "Passante E., Frankish N. The RBL-2H3 cell line: Its provenance and suitability as a model for the mast cell. Inflamm. Res. Off. J. Eur. Histamine Res. Soc. 2009;58:737\u2013745. doi: 10.1007/s00011-009-0074-y.", "ArticleIdList": ["10.1007/s00011-009-0074-y", "19669619"]}, {"Citation": "Choi O.H., Kim J.H., Kinet J.P. Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature. 1996;380:634\u2013636. doi: 10.1038/380634a0.", "ArticleIdList": ["10.1038/380634a0", "8602265"]}, {"Citation": "Ludowyke R.I., Scurr L.L., McNally C.M. Calcium ionophore-induced secretion from mast cells correlates with myosin light chain phosphorylation by protein kinase C. J. Immunol. 1996;157:5130\u20135138.", "ArticleIdList": ["8943424"]}, {"Citation": "Watanabe J., Shinmoto H., Tsushida T. Coumarin and flavone derivatives from estragon and thyme as inhibitors of chemical mediator release from RBL-2H3 Cells. Biosci. Biotechnol. Biochem. 2005;69:1\u20136. doi: 10.1271/bbb.69.1.", "ArticleIdList": ["10.1271/bbb.69.1", "15665459"]}, {"Citation": "Mastuda H. Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-\u03b1 and IL-4 production from RBL-2H3 cells. Bioorganic Med. Chem. 2002;10:3123\u20133128. doi: 10.1016/S0968-0896(02)00227-4.", "ArticleIdList": ["10.1016/S0968-0896(02)00227-4", "12150856"]}, {"Citation": "Park C.-H., Min S.-Y., Yu H.-W., Kim K., Kim S., Lee H.-J., Kim J.-H., Park Y.-J. Effects of Apigenin on RBL-2H3, RAW264.7, and HaCaT Cells: Anti-Allergic, Anti-Inflammatory, and Skin-Protective Activities. Int. J. Mol. Sci. 2020;21:4620. doi: 10.3390/ijms21134620.", "ArticleIdList": ["10.3390/ijms21134620", "PMC7370139", "32610574"]}, {"Citation": "McKay D.L., Blumberg J.B. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.) Phytother. Res. PTR. 2006;20:519\u2013530. doi: 10.1002/ptr.1900.", "ArticleIdList": ["10.1002/ptr.1900", "16628544"]}, {"Citation": "Chirumbolo S. Hormesis, resveratrol and plant-derived polyphenols: Some comments. Hum. Exp. Toxicol. 2011;30:2027\u20132030. doi: 10.1177/0960327111408153.", "ArticleIdList": ["10.1177/0960327111408153", "21558146"]}, {"Citation": "Calabrese E.J., Baldwin L.A. U-Shaped Dose-Responses in Biology, Toxicology, and Public Health. Annu. Rev. Public Health. 2001;22:15\u201333. doi: 10.1146/annurev.publhealth.22.1.15.", "ArticleIdList": ["10.1146/annurev.publhealth.22.1.15", "11274508"]}, {"Citation": "Calabrese V., Cornelius C., Trovato A., Cavallaro M., Mancuso C., Di Rienzo L., Condorelli D., de Lorenzo A., Calabrese E.J. The hormetic role of dietary antioxidants in free radical-related diseases. Curr. Pharm. Des. 2010;16:877\u2013883. doi: 10.2174/138161210790883615.", "ArticleIdList": ["10.2174/138161210790883615", "20388101"]}, {"Citation": "Shin J.Y., Che D.N., Cho B.O., Kang H.J., Kim J., Jang S.I. Commiphora myrrha inhibits itch-associated histamine and IL-31 production in stimulated mast cells. Exp. Ther. Med. 2019;18:1914\u20131920. doi: 10.3892/etm.2019.7721.", "ArticleIdList": ["10.3892/etm.2019.7721", "PMC6676196", "31410154"]}, {"Citation": "Park H.-H., Lee S., Son H.-Y., Park S.-B., Kim M.-S., Choi E.-J., Singh T.S.K., Ha J.-H., Lee M.-G., Kim J.-E., et al. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharmacal Res. 2008;31:1303\u20131311. doi: 10.1007/s12272-001-2110-5.", "ArticleIdList": ["10.1007/s12272-001-2110-5", "18958421"]}, {"Citation": "Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell. 1997;8:2631\u20132645. doi: 10.1091/mbc.8.12.2631.", "ArticleIdList": ["10.1091/mbc.8.12.2631", "PMC25733", "9398681"]}, {"Citation": "Moon T.C., Befus A.D., Kulka M. Mast cell mediators: Their differential release and the secretory pathways involved. Front. Immunol. 2014;5:569. doi: 10.3389/fimmu.2014.00569.", "ArticleIdList": ["10.3389/fimmu.2014.00569", "PMC4231949", "25452755"]}, {"Citation": "Baram D., Adachi R., Medalia O., Tuvim M., Dickey B.F., Mekori Y.A., Sagi-Eisenberg R. Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells. J. Exp. Med. 1999;189:1649\u20131658. doi: 10.1084/jem.189.10.1649.", "ArticleIdList": ["10.1084/jem.189.10.1649", "PMC2193646", "10330444"]}, {"Citation": "Wernersson S., Pejler G. Mast cell secretory granules: Armed for battle. Nat. Rev. Immunol. 2014;14:478\u2013494. doi: 10.1038/nri3690.", "ArticleIdList": ["10.1038/nri3690", "24903914"]}, {"Citation": "Bueno L., Fioramonti J. Protease-activated receptor 2 and gut permeability: A review. Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc. 2008;20:580\u2013587. doi: 10.1111/j.1365-2982.2008.01139.x.", "ArticleIdList": ["10.1111/j.1365-2982.2008.01139.x", "18482083"]}, {"Citation": "Rosenthal R., Luettig J., Hering N.A., Krug S.M., Albrecht U., Fromm M., Schulzke J.-D. Myrrh exerts barrier-stabilising and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells. Int. J. Color. Dis. 2017;32:623\u2013634. doi: 10.1007/s00384-016-2736-x.", "ArticleIdList": ["10.1007/s00384-016-2736-x", "27981377"]}, {"Citation": "Kuehn H.S., Radinger M., Gilfillan A.M. Measuring mast cell mediator release. Curr. Protoc. Immunol. 2010;91:7\u201338. doi: 10.1002/0471142735.im0738s91.", "ArticleIdList": ["10.1002/0471142735.im0738s91", "PMC2982193", "21053305"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "21"}, {"Year": "2022", "Month": "11", "Day": "28"}, {"Year": "2022", "Month": "12", "Day": "1"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "59"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["36559534", "PMC9783512", "10.3390/plants11243422", "plants11243422"]}}], "PubmedBookArticle": []}